Loading clinical trials...
Loading clinical trials...
bmı \> 35 morbidly obese patients requiring endotracheal intubation enrolled in this trial. Divided into two groups Airtraq and ILMA. their effectiveness is evaluated.
80 patients, 18-65 years of aged ASA I-III, BMI\> 35 patients enrolled in this trial. Divided into two groups ; Airtraq and ILMA . BMI\>35, upper airway tumour , respiratory infection less than ten days, excluded from this study. patients demographic and airway variables were recoded. Patients were premedicated. After standard anesthesia induction, anesthesia was induced with propofol and fentanyl. Rocuronium was used for neuromuscular blockade. The device insertion and intubation times, number of intubation attempts, mucosal damage, need for optimization maneuvers, effects on hemodynamic parameters and postoperative minor complications were recorded.
Age
18 - 65 years
Sex
ALL
Healthy Volunteers
No
Kocaeli University School of Medicine
Kocaeli, Turkey (Türkiye)
Start Date
June 1, 2016
Primary Completion Date
November 1, 2016
Completion Date
November 1, 2016
Last Updated
February 3, 2017
80
ACTUAL participants
Airtraq
DEVICE
ILMA
DEVICE
Lead Sponsor
Kocaeli University
NCT07222007
NCT06533436
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions